A third dose of a COVID-19 vaccine boosts the body's immune response, a Texas A&M expert says, giving added protection against Omicron and other variants.
A Texas A&M epidemiologist says the new variant carries concerning mutations, but when it comes to infectiousness and severity, only time will tell.
A discovery by researchers at the Texas A&M College of Medicine could lead to new therapies to prevent the virus from proliferating in the human body.
Any student who has not tested positive for SARS-CoV-2 and has not received a vaccine might be eligible to participate.
Health experts: “We can’t become complacent even though we’re near completion of spring semester.”
A panel of experts recently discussed COVID-19, vaccines, and predictions for future variants during a virtual event.
Texas A&M research shows exposure to high temperatures can neutralize the virus, preventing it from infecting another human host.
The Texas A&M Engineering Experiment Station National Center for Therapeutics Manufacturing meets the need for workers.
A single case led to only mild symptoms. The variant is named BV-1 for its Brazos Valley origin.
A new model developed at Texas A&M has proved successful in predicting COVID-19 infection rates two to three weeks in advance.
It only took eight days for a technology team at Texas A&M Health to develop the Brazos County COVID-19 Vaccination Hub online registration system.
Restrictions lifted on travel within Texas.
The collaborative study shows enzyme inhibitor K777 is effective in combatting SARS-CoV-2.
